MedPath
NMPA Approval

Compound Sodium Picosulfate Granules

国药准字H20249419

November 22, 2024

Drug Information

复方匹可硫酸钠颗粒

颗粒剂

每袋含匹可硫酸钠10mg、氧化镁3.5g和无水枸橼酸12.0g。

化学药品

November 22, 2024

Company Information

Applicant Company

北京市顺义区中北工业区(北石槽镇)

Manufacturing Company

北京市顺义区中北工业区(北石槽镇)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方匹可硫酸钠颗粒 - NMPA 批准文号 | MedPath